Vaccination News Home Page

http://www.medscape.com/viewarticle/438937?mpid=1745&WebLogicSession=PVRqiU2v5lEK4V3Pns8k21097aF1rMtOzvI5Up96vza12RnWZFmC|9062844551221371416/184161395/6/7001/7001/7002/7002/7001/-1

Medscape

 
My Home Page Shortcuts Check Mail Account Settings Log Out REGISTRATION SignIn
MEDLINE Drug Info More...
BROWSE
SEARCH



 

Welcome, S M



HomeCME CenterConference CenterLibraryDiscussionsMarketplaceHelp August 9, 2002  
Email to a Colleague Printable Version Add to My Shortcuts
In This Article

 

Public Health Dispatch: Poliomyelitis - Madagascar, 2002


 

from Morbidity & Mortality Weekly Report
Posted 07/25/2002

 

 


 

Surveillance for acute flaccid paralysis (AFP) in Madagascar has detected a cluster of four cases of paralytic poliomyelitis from which type-2 vaccine-derived polioviruses have been isolated. Preliminary data indicate that these patients, residing in the Tolagnaro district of Toliara province in southeastern Madagascar, had onset of paralysis during March 20--April 12, 2002. None of the children affected was vaccinated fully. During March--April 2002, provincial authorities conducted a small-scale house-to-house vaccination response. Genetic sequencing studies of these vaccine-derived viruses indicate substantial genetic drift and recombination with nonpolio enteroviruses. These findings are compatible with an outbreak of paralytic polio associated with a circulating vaccine-derived poliovirus (cVDPV); however, further investigation is required.

The three outbreaks of cVDPV described previously occurred in areas where routine oral polio vaccine (OPV) coverage is low, AFP surveillance is suboptimal, and supplementary vaccination activities have not been conducted for years [1,2]. Vaccination coverage data suggest that during 1999, 37% of children aged <1 year had received 3 doses of OPV. In 2001, the nonpolio AFP rate of 0.3 case per 100,000 population aged <15 years was below the target level of 1.0.

A joint mission by the Ministry of Health of Madagascar, the Pasteur Institute of Madagascar, the World Health Organization, and United Nations Children's Fund (UNICEF) is ongoing to 1) conduct a field investigation of the cases to verify early reports, 2) review health facility records for any missed cases, 3) enhance the quality of AFP surveillance nationwide, and 4) plan for a nationwide house-to-house polio vaccination response. The work of this mission is being complemented by laboratory work in Madagascar, South Africa, France, and the United States.

Reported by: Ministry of Health; Pasteur Institute, Madagascar. National Institute for Communicable Diseases, South Africa. Pasteur Institute, Paris, France. World Health Organization Regional Office for Africa, Harare, Zimbabwe. Vaccines and Biologicals Dept, World Health Organization, Geneva, Switzerland. Div of Viral and Rickettsial Diseases, National Center for Infectious Diseases; Global Immunization Div, National Immunization Program, CDC.

 

 

   

MMWR 51(28):622, 2002. © 2002 Centers for Disease Control and Prevention (CDC)



 

 


 


 

 


 


Related Resources
 
Clinical articles on this topic

Keyword Search   Advanced Search
 
Medscape  DrugInfo 
Patient Info    MEDLINE 
About Medscape  Privacy & Ethics  Terms of Use  Help

All material on this website is protected by copyright, Copyright © 1994-2002 by Medscape. This website also contains material copyrighted by 3rd parties. Medscape requires 4.x browsers or better from Netscape or Microsoft.

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.